0001209191-14-062657.txt : 20141015
0001209191-14-062657.hdr.sgml : 20141009
20141009164133
ACCESSION NUMBER: 0001209191-14-062657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141007
FILED AS OF DATE: 20141009
DATE AS OF CHANGE: 20141009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calithera Biosciences, Inc.
CENTRAL INDEX KEY: 0001496671
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272366329
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-870-1000
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christoffersen Ralph E
CENTRAL INDEX KEY: 0001316252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36644
FILM NUMBER: 141150488
MAIL ADDRESS:
STREET 1: 4430 ARAPAHOE AVENUE
STREET 2: SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-10-07
0
0001496671
Calithera Biosciences, Inc.
CALA
0001316252
Christoffersen Ralph E
2710 SAND HILL ROAD, SUITE 100
MENLO PARK
CA
94025
1
0
1
0
COMMON STOCK
2014-10-07
4
C
0
1811915
A
1811915
I
By Partnership
COMMON STOCK
2014-10-07
4
P
0
350000
10.00
A
2161915
I
By Partnership
SERIES A PREFERRED STOCK
2014-10-07
4
C
0
10999
0.00
A
COMMON STOCK
10999
0
I
See Footnote
SERIES B PREFERRED STOCK
2014-10-07
4
C
0
419181
0.00
A
COMMON STOCK
419181
0
I
See Footnote
SERIES C PREFERRED STOCK
2014-10-07
4
C
0
747540
0.00
A
COMMON STOCK
747540
0
I
See Footnote
SERIES D PREFERRED STOCK
2014-10-07
4
C
0
634195
0.00
A
COMMON STOCK
634195
0
I
See Footnote
The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately upon consummation of Issuer's initial public offering of Common Stock and had no expiration date.
The securities are held by Morgenthaler Venture Partners IX, L.P. (MVP IX). The managing partner of MVP IX is Morgenthaler Management Partners IX, LLC (MMP IX). Ralph E. Christoffersen, a director of the Issuer is a Member of MMP IX. As such, the Reporting Person shares voting and investment power over the securities held by MMP IX. The Reporting Person disclaims beneficial ownership of the securities held by MMP IX except to the extent of his pecuniary interest therein.
/s/ Ralph E. Christoffersen
2014-10-09